Kihara-Negishi Fumiko, Suzuki Mitsuhiro, Yamada Toshiyuki, Sakurai Takuya, Oikawa Tsuneyuki
Department of Cell Genetics, Sasaki Institute, 2-2 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Biochem Biophys Res Commun. 2005 Sep 23;335(2):477-84. doi: 10.1016/j.bbrc.2005.07.098.
PU.1, a hematopoietic Ets transcription factor, is required for development of the lymphoid and myeloid lineages. We have previously shown that PU.1 functions as both a transcriptional activator and repressor through complex formation with CBP/p300 and HDAC1/mSin3A/MeCP2, respectively. To determine whether modification of PU.1 is responsible for switching its association between co-activators and co-repressors, we examined whether acetylation regulates the physical and functional activities of PU.1. PU.1 was acetylated in vivo and its repressor activity was reduced when the putative acetylation motifs in the Ets domain were mutated. The mutant cooperated with CBP similar to wild type PU.1, but insufficiently with GATA-1 and mSin3A. Whereas overexpression of wild type PU.1 induced differentiation block, growth inhibition, and apoptotic cell death in MEL erythroleukemia cells as we reported previously, overexpression of the mutant-acetylation motif PU.1 did not. Taken together, our data suggest that acetylation might regulate the biological functions of PU.1 in erythroid cells.
PU.1是一种造血Ets转录因子,是淋巴系和髓系细胞发育所必需的。我们之前已经表明,PU.1分别通过与CBP/p300和HDAC1/mSin3A/MeCP2形成复合物,发挥转录激活因子和转录抑制因子的作用。为了确定PU.1的修饰是否负责其在共激活因子和共抑制因子之间的关联转换,我们研究了乙酰化是否调节PU.1的物理和功能活性。PU.1在体内被乙酰化,当Ets结构域中的假定乙酰化基序发生突变时,其抑制活性降低。该突变体与CBP的合作类似于野生型PU.1,但与GATA-1和mSin3A的合作不足。正如我们之前报道的那样,野生型PU.1的过表达在MEL红白血病细胞中诱导分化阻滞、生长抑制和凋亡细胞死亡,而突变乙酰化基序的PU.1过表达则没有。综上所述,我们的数据表明乙酰化可能调节PU.1在红系细胞中的生物学功能。